SymBio Pharmaceuticals Limited (TYO:4582)
Japan flag Japan · Delayed Price · Currency is JPY
65.00
-1.00 (-1.52%)
Aug 21, 2026, 3:30 PM JST

SymBio Pharmaceuticals Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9772,8833,9636,5176,2823,860
Cash & Short-Term Investments
9772,8833,9636,5176,2823,860
Cash Growth
-68.00%-27.25%-39.19%3.74%62.74%0.30%
Accounts Receivable
1502594239132,0842,148
Receivables
1502594239132,0842,148
Inventory
150288238232469385.68
Prepaid Expenses
26060110119209145.01
Other Current Assets
328334190301268209.53
Total Current Assets
1,8653,8244,9248,0829,3126,748
Property, Plant & Equipment
----6983.64
Long-Term Investments
3738448785-
Other Intangible Assets
----222259.1
Long-Term Deferred Tax Assets
45--7441,276
Other Long-Term Assets
1--1186.66
Total Assets
1,9073,8674,9688,17010,4338,453

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
----4669.68
Accrued Expenses
-----516.04
Current Portion of Long-Term Debt
832682----
Current Income Taxes Payable
1,6315867378721,564383.6
Other Current Liabilities
22222984313548.79
Total Current Liabilities
2,4851,2907669561,9231,518
Long-Term Debt
-1,300----
Pension & Post-Retirement Benefits
444332.78
Other Long-Term Liabilities
13312186.44
Total Liabilities
2,4902,5977739601,9281,707

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
20,16319,24418,33617,95217,54817,158
Additional Paid-In Capital
20,13819,21818,31117,92717,52317,133
Retained Earnings
-41,081-37,461-32,685-28,852-26,889-27,978
Treasury Stock
-89-89-89-89-88-86.05
Comprehensive Income & Other
286358322272411519.1
Shareholders' Equity
-5831,2704,1957,2108,5056,746
Total Liabilities & Equity
1,9073,8674,9688,17010,4338,453

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
8321,982----
Net Cash (Debt)
1459013,9636,5176,2823,860
Net Cash Growth
-91.73%-77.27%-39.19%3.74%62.74%0.30%
Net Cash Per Share
2.3517.9487.88163.32158.6299.38
Filing Date Shares Outstanding
76.3471.7847.8344.7539.5238.37
Total Common Shares Outstanding
76.3459.4845.8442.1939.5238.37
Working Capital
-6202,5344,1587,1267,3895,230
Book Value Per Share
-7.6421.3591.52170.89215.22175.78
Tangible Book Value
-5831,2704,1957,2108,2836,487
Tangible Book Value Per Share
-7.6421.3591.52170.89209.60169.03
Buildings
-----64.62
Machinery
-----72.73